Human Formulations

Diclofenac Sodium 50mg + Thiocolchicoside 4mg Capsule

Diclofenac Sodium 50mg + Thiocolchicoside 4mg Capsule is a capsule formulated with Diclofenac Sodium 50mg + Thiocolchicoside 4mg. The listed active ingredient profile is Diclofenac Sodium; Thiocolchicoside, placing the product in the pain / musculoskeleta

CapsulesNon-Beta-Lactam Capsules Single Ingredient Capsule
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Capsules, Non-Beta-Lactam Capsules
Dosage Form
Capsule
Product Type
Single Ingredient

Available strengths

Diclofenac Sodium 50mg + Thiocolchicoside 4mgDiclofenac Sodium 50mg + Thiocolchicoside 8mg

Description

Diclofenac Sodium 50mg + Thiocolchicoside 4mg Capsule is a capsule formulated with Diclofenac Sodium 50mg + Thiocolchicoside 4mg. The listed active ingredient profile is Diclofenac Sodium; Thiocolchicoside, placing the product in the pain / musculoskeletal category. The formulation contains analgesic, anti-inflammatory and/or muscle-relaxant components used in selected musculoskeletal pain conditions. The source identifies the dosage form as capsule with not specified presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured